CervoMed Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.4M | $-18.0M | $-6.7M | $-14.4M | $-2.5M | $-6.9M | $-22.6M | $-8.4M |
| Depreciation & Amortization | — | — | $23.3K | $566.3K | $116.4K | $164.0K | $69.8K | $49.7K |
| Depreciation | $68.0K | $25.3K | $8.0K | $11.9K | $40.9K | $26.8K | $119.8K | — |
| Amortization | — | — | $0 | $554.3K | — | — | — | — |
| Stock-Based Compensation | $1.2M | $1.4M | $594.2K | $1.6M | $2.2M | — | — | — |
| Net Cash from Operating Activities | $-12.3M | $-10.8M | $-5.2M | $-9.0M | $-1.2M | $-4.3M | $-12.0M | $-2.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $447.8K | $2.3K | $40.3K | $50.9K | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | $358.8K | $1.4M |
| Net Cash from Investing Activities | $-447.8K | $8.5M | $2.5M | $-50.9K | — | — | $-985.9K | $-1.4M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $20.1M | $1.8M | $2.4M | $30.7M | $1.1M | $4.5M | $13.1M | $3.4M |
| Net Change in Cash | $7.3M | $-444.3K | $-339.3K | $21.6M | $-57.1K | $213.6K | $98.4K | — |
| Free Cash Flow | $-12.8M | $-10.8M | $-5.2M | $-9.1M | — | — | — | — |